Vildanat Tablet
Marketer
Natco Pharma Ltd
Salt Composition
Vildagliptin (50mg)
Overview Vildanat Tablet
Glyconia tablets are indicated for the management of type 2 diabetes. Optimal blood glucose control is achieved through concurrent adherence to a balanced diet and regular physical activity, thus mitigating the risk of severe diabetic complications, such as renal impairment and vision loss. Glyconia is typically prescribed when dietary and exercise modifications, or other medications, prove inadequate. It may be administered alone or in conjunction with other antidiabetic agents. Administration is independent of food intake. Dosage is individualized based on the patient's condition and glycemic profile. Strict adherence to the physician's prescribed regimen is crucial. Consistent daily dosing at the same time maximizes therapeutic benefit. Discontinuation should only occur under medical supervision. Continued commitment to the recommended diet and exercise program is paramount. Lifestyle choices significantly impact diabetes management. Common adverse effects include hypoglycemia, tremors, cephalalgia, vertigo, lassitude, and nausea. Recognizing hypoglycemic symptoms (lightheadedness, diaphoresis, dizziness, syncope, xerostomia) and appropriate countermeasures (e.g., glucose tablets) is vital. Persistent or concerning side effects warrant immediate medical attention. Prior to initiating therapy, patients with a history of renal, cardiac, or pancreatic disorders should inform their physician. Pregnant or lactating individuals require specific medical guidance. Potential drug interactions necessitate disclosure of all concurrent medications. Alcohol consumption should be moderated due to an increased hypoglycemia risk. Regular monitoring of renal function and blood glucose levels ensures optimal therapeutic efficacy.
Primary Ingredients of Vildanat Tablet
No information provided. Please provide the text you wish to be rephrased.
Uses of Vildanat Tablet
Managing type 2 diabetes
Major Benefits of Vildanat Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vildanat Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Vildanat Tablet:
- Hypoglycemia (low blood glucose level)
- Tremors
- Headache
- Dizziness
- Fatigue
- Nausea
How to use Vildanat Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vildanat Tablets can be consumed with or without food, though consistent timing is recommended.
How Vildanat Tablet works:
Vildanat tablets manage blood sugar by stimulating insulin secretion from the pancreas and suppressing hyperglycemic hormones. This dual action lowers both fasting and postprandial glucose concentrations.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Vildanat Tablet lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
The use of Vildanat Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against these risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Vildanat Tablet use are likely incompatible. Available human data indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Vildanat tablets may cause drowsiness, blurred vision, and dizziness, reducing alertness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Vildanat tablets are generally safe for individuals with kidney disease, and typically require no dosage modification. Nevertheless, patients experiencing moderate to severe kidney impairment may need adjusted dosing. Physician consultation is advised.
LiverUNSAFE
Patients with liver conditions should likely avoid Vildanat tablets due to potential safety concerns. A physician's consultation is recommended.
What if you forget to take Vildanat Tablet :
Should you forget a Vildanat Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Vildanat Tablet
| Label | Value |
|---|---|
| Chemical Type | Pyrrolidinecarbonitrile |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Dipeptidyl peptidase-4 inhibitors |



